Teleflex Announces Publication of a Large Real-World Study Confirming Results from Controlled Clinical Studies of the UroLift® System

NEXT STORY
Cara Therapeutics Announces Initiation of Phase 2 Trial of Oral KORSUVA™ (CR845/difelikefalin) for Pruritus in Patients with Atopic Dermatitis
PREV STORY
Oasmia discontinues cooperation with former executive chairman
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Celsion Corporation Reports First Quarter 2017 Financial Results and Provides Business Update

LAWRENCEVILLE, N.J., May 12, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), an oncology drug ...

author_avatar
NASDAQ Market News

Jounce Therapeutics Reports Third Quarter 2018 Financial Results

- Dose escalation cohorts of JTX-2011 Phase 1/2 ICONIC trial, in combination with ipilimumab ...

author_avatar
NASDAQ Market News

Oncolytics Biotech® Announces Collaboration with Merck and Northwestern University Combining Keytruda® and REOLYSIN® in a Phase 2 Second Line Pancreatic Cancer Study

CALGARY, Alberta and SAN DIEGO, May 17, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. ...

author_avatar
NASDAQ Market News